An Inverse Relation Between the Expression of Tumor Necrosis Factor Alpha (TNF‐α) and TNF‐α Receptor in Human Endometrium
- 1 November 1999
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 42 (5) , 297-302
- https://doi.org/10.1111/j.1600-0897.1999.tb00105.x
Abstract
To determine whether the expression of tumor necrosis factor (TNF-alpha) correlates with TNF-alpha receptor expression in human endometrium. A multiprimer synthetic cDNA standard template containing complimentary sequences for several cytokines including TNF-alpha and TNF-alpha receptor type 2 was constructed and used in quantitative reverse transcription polymerase chain reaction (Q-RT-PCR). Endometrium from proliferative phase of the menstrual cycle expresses higher levels of TNF-alpha mRNA (2.35 +/- 0.2 x 10(5) copies/microg of total cellular RNA) than secretory phase ([1.3 +/- 0.08 x 10(5) copies] P < 0.05), with a significant reduction during menses (1.2 +/- 0.1 x 10(4) copies) and postmenopausal period (8.1 +/- 1.6 x 10(4) copies [P < 0.05]). In contrast, TNF-alpha type 1 receptor mRNA expression was higher in endometrium from the secretory phase (6.6 +/- 0.6 x 10(7) copies) compared to the menses (5.1 +/- 0.5 x 10(6) copies), proliferative phase (1.9 +/- 0.1 x 10(6) copies) and postmenopausal period (5.8 +/- 0.7 x 10(4) copies [P < 0.05]). Comparatively, TNF-alpha receptor type 2 is expressed 10 to 100 fold higher in the endometrium than TNF-alpha (P < 0.05). The data confirm that human endometrium expresses TNF-alpha; and provide the first evidence that TNF-alpha expression is inversely related to TNF-alpha type 1 receptor expression during the menstrual cycle. Such an inverse relation between TNF-alpha and TNF-alpha receptor expression may provide a regulatory mechanism necessary to overcome the detrimental effect of high levels of TNF-alpha on various endometrial cell types.Keywords
This publication has 14 references indexed in Scilit:
- Expression of integrin messenger ribonucleic acid in human endometrium: a quantitative reverse transcription polymerase chain reaction studyFertility and Sterility, 1999
- Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapyJournal of Clinical Endocrinology & Metabolism, 1996
- Peritoneal Growth Factors and EndometriosisSeminars in Reproductive Medicine, 1996
- The Tumor Necrosis Factor Ligand and Receptor FamiliesNew England Journal of Medicine, 1996
- The production of tumour necrosis factor a (TNF- ) by human endometrial cells in cultureHuman Reproduction, 1996
- Cytokines in implantationHuman Reproduction Update, 1995
- Tumour necrosis factor-α-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/β-catenin and disassembly of actin filamentsMolecular Human Reproduction, 1995
- Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites.Endocrinology, 1994
- Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sitesEndocrinology, 1994
- Cytokine expression in human endometrium throughout the menstrual cycleHuman Reproduction, 1992